MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
298<br />
yet <strong>ME</strong> does not exist ‐‐ Professor Wessely and his acolytes say so, and the MRC apparently accepts the<br />
Wessely School’s beliefs.<br />
Comment<strong>in</strong>g on the tragic case of Pamela Weston (an <strong>ME</strong> sufferer who committed suicide at the Dignitas<br />
cl<strong>in</strong>ic <strong>in</strong> Switzerland), on 27 th September 2009 Dr Matthew Harris from Exeter wrote <strong>in</strong> The Times onl<strong>in</strong>e:<br />
“The assertion ‘many doctors believe <strong>ME</strong> has a psychological rather than a physical cause’ contradicts the Royal<br />
College of General Practitioners, which reclassified <strong>ME</strong> as a physical illness <strong>in</strong> August 2008. The statement may be<br />
re‐phrased to say a m<strong>in</strong>ority of psychiatrists th<strong>in</strong>k <strong>ME</strong> is psychological. In fact, many doctors are hop<strong>in</strong>g that<br />
the NICE guidel<strong>in</strong>es will be amended to reflect the current understand<strong>in</strong>g of <strong>ME</strong> as physical <strong>in</strong> orig<strong>in</strong> and<br />
physiological <strong>in</strong> its development, so as to provide a more practical model for general practice”.<br />
Accord<strong>in</strong>g to Professor Mart<strong>in</strong> Pall, the PACE Trial is predicated on three obvious failures: (i) the<br />
psychogenic advocates fail to expla<strong>in</strong> the vast amount of genu<strong>in</strong>e pathophysiological changes found <strong>in</strong><br />
sufferers of <strong>ME</strong>/CFS; (ii) the “biopsychosocial” construct is built on ignorance and its whole basis has no<br />
foundation and (iii) the Wessely School’s claims that <strong>ME</strong>/CFS is a functional somatic syndrome are specious<br />
because there are biomedical explanations for the protean symptoms of <strong>ME</strong>/CFS.<br />
It should not be forgotten that one of the PACE Trial’s Pr<strong>in</strong>cipal <strong>Invest</strong>igators, Professor Michael Sharpe,<br />
is on record thus: “Purchasers and Health Care providers with hard pressed budgets are understandably<br />
reluctant to spend money on patients for whom there is controversy about the ‘reality’ of their condition<br />
(and who) are <strong>in</strong> this sense undeserv<strong>in</strong>g of treatment…Those who cannot be fitted <strong>in</strong>to a scheme of objective<br />
bodily illness yet refuse to be placed <strong>in</strong>to and accept the stigma of mental illness rema<strong>in</strong> the undeserv<strong>in</strong>g<br />
sick of our society and our health service” (<strong>ME</strong>: What do we know: real illness or all <strong>in</strong> the m<strong>in</strong>d? Lecture<br />
given by Michael Sharpe <strong>in</strong> October 1999, hosted by the University of Strathclyde).<br />
No matter what the latest UK Government policy happens to be, given the body of biomedical evidence<br />
that exists about <strong>ME</strong>/CFS, for the MRC to fund out of taxpayers’ money trials that appear to have no<br />
scientific <strong>in</strong>tegrity or value seems <strong>in</strong>defensible.<br />
UK/US Interactions<br />
In the US <strong>ME</strong>/CFS was designated by the Centres for Disease Control as “A serious legitimate diagnosis<br />
CDC Priority 1 Disease of Public Health importance”, not as a behavioural disorder as <strong>in</strong> the UK.<br />
However, it seems that it is no longer categorised thus, and that the Wessely School has set out to change<br />
that previous situation <strong>in</strong> the US <strong>in</strong> order to br<strong>in</strong>g it <strong>in</strong> l<strong>in</strong>e with the situation <strong>in</strong> the UK, aim<strong>in</strong>g at an<br />
“<strong>in</strong>ternational consensus” about how “CFS/<strong>ME</strong>” should be managed.<br />
The M<strong>in</strong>utes of the Health & Human Services CFS Advisory Committee meet<strong>in</strong>g on 27 th and 28 th May 2009<br />
held <strong>in</strong> Wash<strong>in</strong>gton DC record that Dr William Reeves of the CDC said that the CDC wanted to get together<br />
an <strong>in</strong>ternational workshop on “CFS” by w<strong>in</strong>ter 2009: “We want to <strong>in</strong>clude countries such as the UK that<br />
have CFS care completely <strong>in</strong>tegrated <strong>in</strong>to their healthcare system….The collaboration with Peter White is<br />
largely because Peter White came to us when the National Health Service <strong>in</strong> the UK was try<strong>in</strong>g to design its<br />
programme and formulate recommendations about what the health service <strong>in</strong> the UK should do…and we<br />
collaborate with Dr White on the PACE Trial. An <strong>in</strong>ternational meet<strong>in</strong>g provides the chance to learn from<br />
another government that has embraced this illness”.<br />
The Chair of the CFS Advisory Committee, Dr Oleske, responded: “I have to say that I th<strong>in</strong>k there are times<br />
when the domestic agenda suffers at the behest of an <strong>in</strong>ternational agenda” and a member of the CFS<br />
Advisory Committee (Ms Artman) said that when she had contacted those who participated <strong>in</strong> the CDC<br />
stakeholder meet<strong>in</strong>g, “Just about everyone came back with comments about either Simon Wessely or Peter